Bavarian Nordic A/S
2.2.2026 08:54:02 CET | Globenewswire | Press release
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
COPENHAGEN, Denmark, February 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 7, 2026, under which the Company will repurchase shares for an amount up to DKK 150 million in the period from January 7, 2026 to February 13, 2026. The program is executed in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.
Since the last announcement of transactions on January 26, 2026, the following transactions have been made by Nordea on behalf of Bavarian Nordic:
| Number of shares | Average purchase price, DKK | Transaction value, DKK | |
| Accumulated until January 26, 2026 | 439,121 | 197.47 | 86,712,870 |
| January 26, 2026 | 3,389 | 196.90 | 667,294 |
| January 27, 2026 | 36,000 | 198.11 | 7,131,928 |
| January 28, 2026 | 78,000 | 196.42 | 15,320,737 |
| January 29, 2026 | 79,000 | 192.07 | 15,173,206 |
| January 30, 2026 | 799 | 190.87 | 152,504 |
| Accumulated under the program | 636,309 | 196.69 | 125,158,539 |
The details for each transaction made under the share repurchase program are published on bavarian-nordic.com.
Following these transactions, Bavarian Nordic holds a total of 1,603,154 treasury shares, corresponding to 2.02% of the Company’s share capital.
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly
Contact investors:
Europe: Disa Tuominen, IR Manager, detu@bavarian-nordic.com
US: Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600
Contact media:
Nicole Seroff, Vice President Corporate Communications, nise@bavarian-nordic.com, Tel: +45 53 88 06 03
Company Announcement no. 05 / 2026
Attachments
- Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
- Appendix with detailed transaction data
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Ministry of Information & Broadcasting, Pakistan15.8.2026 18:49:59 CEST | Press release
Ministry of Information & Broadcasting, Pakistan: The Morning After - An Independence Day Message
Rapala VMC Oyj14.8.2026 20:40:00 CEST | Press release
Inside information: Rapala VMC Corporation issues a positive profit warning: expects full year comparable operating profit to be in the range of 12 to 14 MEUR
Solvay S.A.14.8.2026 17:45:00 CEST | Press release
Participation notifications by Citigroup Inc.
Vislink LTD14.8.2026 16:36:46 CEST | Press release
Vislink Reports Second Quarter 2026 Financial Results
Pixocial Technology (Singapore) Pte. Ltd.14.8.2026 16:01:00 CEST | Press release
BeautyPlus Launches AI Influencer Generator for Consistent Virtual Content Creation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom